Your browser doesn't support javascript.
COVID and Lung Cancer.
Calabrò, Luana; Rossi, Giulia; Covre, Alessia; Morra, Aldo; Maio, Michele.
  • Calabrò L; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy. l.calabro@ao-siena.toscana.it.
  • Rossi G; EPigenetic Immune-Oncology Consortium Airc (EPICA), Viale Mario Bracci, 16; 53100, Siena, Italy. l.calabro@ao-siena.toscana.it.
  • Covre A; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy.
  • Morra A; Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Siena, Italy.
  • Maio M; EPigenetic Immune-Oncology Consortium Airc (EPICA), Viale Mario Bracci, 16; 53100, Siena, Italy.
Curr Oncol Rep ; 23(11): 134, 2021 10 22.
Article in English | MEDLINE | ID: covidwho-1530397
ABSTRACT
PURPOSE OF REVIEW Since the past year, the fast spread of coronavirus disease 2019 (COVID-19) has represented a global health threat, especially for cancer patients, that has required an urgent reorganization of clinical activities. Here, we will critically revise the profound impact that the pandemic has generated in lung cancer patients, as well the most significant challenges that oncologists have to face to maintain the highest possible standards in the management of lung cancer patients in the pandemic era. RECENT

FINDINGS:

Evidences suggested a higher susceptibility and mortality of lung cancer patients due to COVID-19. The hard management of this patient population has been also due to the potential cross interference of anti-tumor drugs on SARS-Cov-2 infection and to the differential diagnosis between COVID-19 pneumonitis and drug-related pneumonitis. COVID-19 pandemic has generated a profound reshaping of oncological activities and the development of recommendations by the oncology scientific community to prioritize anti-tumor treatments for lung cancer patients.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia / COVID-19 / Lung Neoplasms Type of study: Diagnostic study / Prognostic study / Randomized controlled trials Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: Curr Oncol Rep Journal subject: Neoplasms Year: 2021 Document Type: Article Affiliation country: S11912-021-01125-8

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia / COVID-19 / Lung Neoplasms Type of study: Diagnostic study / Prognostic study / Randomized controlled trials Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: Curr Oncol Rep Journal subject: Neoplasms Year: 2021 Document Type: Article Affiliation country: S11912-021-01125-8